Testosterone Enanthate & Boldenone Undecylenate mix

BLEND 400
Producer: Euro-Pharmacies
Type: Injectable
Unit dosage: 400 mg/ml
Packaging: 10 ml vial
Form: Liquid
Active agent: 200 mg Testosterone Enanthate, 200 mg Boldenone Undecylenate
Drug half-life: 15–16 days (Testosterone Enanthate), 14–16 days (Boldenone Undecylenate)
Category: AAS (Anabolic Androgenic Steroids)
Dosage: 250–1000 mg/week for Testosterone Enanthate, 400–600 mg/week for Boldenone Undecylenate
Water retention: Yes
Aromatization: Yes

Information:
BLEND 400 combines two effective compounds: 200 mg of Testosterone Enanthate and 200 mg of Boldenone Undecylenate. Testosterone Enanthate is renowned for its strong anabolic and androgenic effects and its slow release into the bloodstream, offering prolonged activity. Boldenone Undecylenate complements it with anabolic properties that support muscle development. Together, they provide a balanced formula that ensures steady testosterone levels and promotes lean muscle growth.

Effects:

• Enhanced muscle definition
• Increased strength
• Joint pain relief
• Boosted energy levels
• Accelerated recovery

This combination offers comprehensive benefits for physical transformation and performance improvement.

Dosage and Duration:

• Typical dosage: 400 mg/ml per week, adjusted based on individual needs.
• Advanced users may increase up to 600 mg/ml per week, though caution is advised due to potential side effects.
• Recommended cycle length: 8–12 weeks for optimal benefits while minimizing long-term risks.

Possible Side Effects:

• Acne: Due to increased oil production.
• Water retention: May result in temporary bloating.
• High blood pressure: Regular monitoring is necessary.
• Testicular shrinkage: Reversible with proper post-cycle therapy.

Combining With Other Medications:

• Dianabol: Enhances muscle mass and strength gains.
• Anadrol: Promotes rapid muscle-building and recovery.
• Trenbolone: Supports lean muscle development and vascularity.
• Testosterone esters: Increases anabolic effects for better overall results.